Suzanne Norris Selected Research

Suzanne Norris Research Topics

Disease

14	Infections 01/2018 - 07/2002
9	Hepatitis C 10/2019 - 07/2002
9	Chronic Hepatitis C 01/2019 - 07/2002
8	Liver Diseases (Liver Disease) 05/2015 - 05/2002
5	Hemochromatosis (Bronze Diabetes) 02/2020 - 07/2007
5	Fibrosis (Cirrhosis) 01/2018 - 07/2002
3	Iron Overload 02/2020 - 03/2010
3	Neoplasms (Cancer) 09/2017 - 05/2002
2	Insulin Resistance 12/2010 - 03/2010
2	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 01/2008 - 07/2007
1	Frailty 01/2022
1	Fatigue 01/2021
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Gastroesophageal Reflux (GERD) 01/2019
1	Coinfection 01/2018
1	Carcinogenesis 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 10/2015
1	Neutropenia 12/2010
1	Hepatitis 02/2008
1	Cystic Fibrosis (Mucoviscidosis) 01/2008
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Hemorrhage 12/2007
1	Varicose Veins (Varicose Vein) 12/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2007
1	Persistent Infection 10/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2006
1	Hematologic Neoplasms (Hematological Malignancy) 07/2005
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2005
1	End Stage Liver Disease 07/2005
1	Lymphoma (Lymphomas) 07/2005
1	Sepsis (Septicemia) 10/2004
1	Lactic Acidosis 05/2004
1	Drug-Related Side Effects and Adverse Reactions 05/2004
1	Inflammation (Inflammations) 09/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2003
1	Necrosis 01/2003
1	Autoimmune Hepatitis 10/2002
1	Cytomegalovirus Infections (Inclusion Disease) 08/2002

Drug/Important Bio-Agent (IBA)

7	InterferonsIBA 01/2018 - 10/2007
6	Antiviral Agents (Antivirals)IBA 01/2018 - 10/2004
4	Pharmaceutical PreparationsIBA 10/2019 - 10/2002
3	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 12/2010
3	Proteins (Proteins, Gene)FDA Link 01/2008 - 07/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 08/2002
2	Interferon-alpha (Interferon Alfa)IBA 07/2014 - 09/2012
2	Insulin (Novolin)FDA Link 12/2010 - 03/2010
2	Glucose (Dextrose)FDA LinkGeneric 12/2010 - 03/2010
2	C-PeptideIBA 12/2010 - 03/2010
2	CytokinesIBA 10/2007 - 07/2002
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	ombitasvirIBA 01/2019
1	paritaprevirIBA 01/2019
1	Rho(D) Immune Globulin (RhoGAM)IBA 12/2017
1	Hepatitis B Core AntigensIBA 09/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2017
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2015
1	SimeprevirIBA 01/2015
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015
1	telaprevirIBA 01/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2014
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2012
1	HLA-A Antigens (HLA-A)IBA 11/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2011
1	Biological ProductsIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2010
1	Toll-Like Receptor AgonistsIBA 12/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2010
1	IronIBA 03/2010
1	ursodoxicoltaurineIBA 07/2008
1	Mutant Proteins (Protein, Mutant)IBA 01/2008
1	ChemokinesIBA 10/2007
1	EnzymesIBA 10/2007
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 07/2007
1	Hemochromatosis ProteinIBA 07/2007
1	Peptides (Polypeptides)IBA 02/2006
1	Rituximab (Mabthera)FDA Link 07/2005
1	Reverse Transcriptase InhibitorsIBA 05/2004
1	NucleosidesIBA 05/2004
1	AutoantibodiesIBA 05/2003
1	Messenger RNA (mRNA)IBA 01/2003
1	Fas Ligand Protein (Fas Ligand)IBA 01/2003
1	Granzymes (Granzyme)IBA 01/2003
1	PerforinIBA 01/2003
1	Azathioprine (Imuran)FDA LinkGeneric 10/2002
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 10/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2002
1	Viral DNAIBA 08/2002

Therapy/Procedure

11	Therapeutics 02/2020 - 10/2002
6	Liver Transplantation 01/2022 - 05/2002
4	Transplantation 10/2015 - 05/2002
1	Medication Reconciliation 10/2019
1	Highly Active Antiretroviral Therapy (HAART) 02/2008
1	Transjugular Intrahepatic Portasystemic Shunt 12/2007
1	Gastrectomy 07/2005
1	Ligation 01/2003